Publication
Gene therapy products in Canada
In recent years, the incredible promise of gene therapy has become a reality as multiple gene therapy products have come to market.
Marjorie Glover, David Gallai and Rachel Kurth write a monthly column in the Employee Benefit Plan Review providing expert insight into employee benefits questions. This month's article addresses questions concerning responsibility for COBRA continuation coverage in M&A transactions, providing form W-2 to employees with minimal compensation, simple employee plan eligibility and simple employee pension plan contributions.
Publication
In recent years, the incredible promise of gene therapy has become a reality as multiple gene therapy products have come to market.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023